Stock Earnings

Question 1

Abcellera Biologics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Abcellera Biologics Inc 的总资产为 $1,360，净loss为 $-162

Question 2

ABCL 的关键财务比率是什么？

Accepted Answer

Abcellera Biologics Inc 的流动比率是 4.47，净利 margin 为 -578.57，每股销售为 $0.09。

Question 3

Abcellera Biologics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Abcellera Biologics Inc largest revenue segment is Antibodies, at a revenue of 28,833,000 in the most earnings release.For geography, Canada is the primary market for Abcellera Biologics Inc, at a revenue of 26,200,000.

Question 4

Abcellera Biologics Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Abcellera Biologics Inc 的净loss为 $-162

Question 5

Abcellera Biologics Inc 有负债吗？

Accepted Answer

yes，Abcellera Biologics Inc 的负债为 304

Question 6

Abcellera Biologics Inc 的流通股有多少？

Accepted Answer

Abcellera Biologics Inc 的总流通股为 295.75

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	35	28	38	485	375	233
Revenue Growth (YoY)	9%	-26%	-92%	28.99%	61%	2,018%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	85	85	75	66	48	15
Research & Development	182	167	175	107	62	29
Operating Expenses	296	343	275	268	170	77
Other Non Operating Income (Expenses)	7	58	17	10	17	8
Pretax Income	-204	-200	-174	239	219	157
Income Tax Expense	-33	-37	-27	80	65	38
Net Income	-171	-162	-146	158	153	118
Net Income Growth	-2%	11%	-192%	3%	30%	-6,000%
Shares Outstanding (Diluted)	298.87	294.32	289.16	314.8	318.3	269.5
Shares Change (YoY)	1%	2%	-8%	-1%	18%	1%
EPS (Diluted)	-0.57	-0.55	-0.5	0.5	0.48	0.44
EPS Growth	-4%	9%	-200.99%	4%	9%	-4,500%
Free Cash Flow	-153	-186	-121	204	186	8
Free Cash Flow Per Share	-0.51	-0.63	-0.41	0.64	0.58	0.02
Gross Margin	--	--	--	--	--	--
Operating Margin	-745.71%	-1,121.42%	-623.68%	44.53%	54.4%	66.95%
Profit Margin	-488.57%	-578.57%	-384.21%	32.57%	40.8%	50.64%
Free Cash Flow Margin	-437.14%	-664.28%	-318.42%	42.06%	49.6%	3.43%
EBITDA	-238	-224	-213	243	218	160
EBITDA Margin	-680%	-800%	-560.52%	50.1%	58.13%	68.66%
D&A For EBITDA	23	90	24	27	14	4
EBIT	-261	-314	-237	216	204	156
EBIT Margin	-745.71%	-1,121.42%	-623.68%	44.53%	54.4%	66.95%
Effective Tax Rate	16.17%	18.5%	15.51%	33.47%	29.68%	24.2%

Abcellera Biologics Inc (ABCL) Price

ABCL Stock Price Chart

ABCL Income

Follow-Up Questions